NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Dabur India Ltd. Invests ₹60 Crore in RAS Beauty

Key Highlights

  • Dabur India Ltd. has invested ₹60 crore for a minority stake in RAS Beauty, a luxury 'farm-to-face' skincare brand.
  • RAS Beauty has previously received investments from Unilever and Amazon.

Financial Impact

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

The investment is relatively insignificant compared to Dabur India Ltd.'s consolidated revenue of ₹12,500 crore for FY25. Despite this, the investment marks a strategic move by the company to expand its portfolio in the skincare sector.

Investment Details

The ₹60 crore investment is a minority stake acquisition, indicating that Dabur India Ltd. will maintain a minority ownership in RAS Beauty. The investment is part of the company's efforts to diversify its product offerings and tap into the growing demand for luxury skincare products.

Investor Takeaway

Dabur's investment in RAS Beauty presents growth opportunities with minimal financial risks.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.